📇 Rhumatologue · CHEVILLY LARUE · (94) · Libéral
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
1 raison identifiée
Délais de RDV courts dans la région
134 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
CABINET DU DR OLIVIER LAVERDURE
24 RUE PASTEUR, 94550 CHEVILLY LARUE
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Cerebrovascular diseases (Basel, Switzerland) · 2018
<b><i>Objective:</i></b> The purpose of this study was to demonstrate that the median door-to-needle (DTN) time for intravenous tissue plasminogen activator (tPA) treatment can be reduced to 45 min in a primary stroke centre with MRI-based screening for acute ischaemic stroke (AIS). <b><i>Methods:</i></b> From February 2015 to February 2017, the stroke unit of Perpignan general hospital, France, implemented a quality-improvement (QI) process. During this period, patients who received tPA within 4.5 h after AIS onset were included in the QI cohort. Their clinical characteristics and timing metrics were compared each semester and also with those of 135 consecutive patients with AIS treated by tPA during the 1-year pre-QI period (pre-QI cohort). <b><i>Results:</i></b> In the QI cohort, 274 patients (92.5%) underwent MRI screening. While the demographic and baseline characteristics were not significantly different between cohorts, the median DTN time was significantly lower in the QI than in the pre-QI cohort (52 vs. 84 min; <i>p</i> &#x3c; 0.00001). Within the QI cohort, the median DTN time for each semester decreased from 65 to 44 min (<i>p</i> &#x3c; 0.00001) and the proportion of treated patients with a DTN time ≤45 min increased from 25 to 58.9% (<i>p</i> &#x3c; 0.0001). Overall, DTN time improvement was associated with a better outcome at 3 months (patients with a modified Rankin Scale score between 0 and 2: 61.8% in the QI vs. 39.3% in the pre-QI cohort; <i>p</i> &#x3c; 0.0001). <b><i>Conclusions:</i></b> A QI process can reduce the DTN within 45 min with MRI as a screening tool.
Revue neurologique · 2017
Revue neurologique · 2022
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Revue neurologique · 2022 · Observational Study
Sablot D, Leibinger F, Dutray A, Van Damme L, et al.
Journal of neurology · 2021 · Journal Article
Leibinger F, Allou T, Van Damme L, Jebali C, et al.
Revue neurologique · 2017 · Journal Article
Sablot D, Gaillard N, Colas C, Smadja P, et al.
Cerebrovascular diseases (Basel, Switzerland) · 2018 · Journal Article
Sablot D, Ion I, Khlifa K, Farouil G, et al.